Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 4/20 | 0.41 |
| ▸ | ADH1A | P07327 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | ADH1C | P00326 | 3/20 | 0.38 |
| ▸ | ADH7 | P40394 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ADH4 | P08319 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6827228 | 0.81 | ADH1B (0.42) | ADH1BADH1AADH1CADH7KMT2A | |
| SCHEMBL3842328 | 0.81 | ADH1B (0.42) | ADH1BADH1AADH1CADH7KMT2A | |
| SCHEMBL12385241 | 0.80 | GAA (0.46) | GAAKDM4EL3MBTL1KMT2AALDH1A1 | |
| SCHEMBL9341864 | 0.79 | ADH1B (0.37) | ADH1BADH1AADH1CADH7ADH4 | |
| SCHEMBL1818885 | 0.76 | GAA (0.45) | GAAL3MBTL1 | |
| SCHEMBL2875979 | 0.73 | GAA (0.44) | GAAKDM4EL3MBTL1KMT2AALDH1A1 | |
| SCHEMBL13172679 | 0.72 | GAA (0.53) | GAAKDM4EL3MBTL1KMT2AALDH1A1 | |
| SCHEMBL13172621 | 0.72 | GAA (0.53) | GAAKDM4EL3MBTL1KMT2AALDH1A1 | |
| SCHEMBL14409879 | 0.71 | GAA (0.43) | GAAKDM4EL3MBTL1KMT2AALDH1A1 | |
| SCHEMBL90869 | 0.71 | ADH1B (0.46) | ADH1BADH1AADH1CADH7ADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6740528-B2 | MONITORING REACTIVE IONS IN SAMPLE; OBTAIN SAMPLE, INCUBATE WITH MODULATOR OF IONIC ACTIVITY, ANALYZE WITH ELECTRON SPIN RESONANCE, COUNT REACTIVE IONS | HAKUTO CO., LTD. (JP) | 2004-05-25 | — | — | US | claimed |
| US-20020048820-A1 | Method for measuring concentration of stable free radical compound | HAKUTO CO., LTD. | 2002-04-25 | — | — | US | claimed |
| EP-1095006-A1 | DERIVATIVES OF 1-OXYL-4-HYDROXY-OR 4-AMINO-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH) ACRYLATE MONOMERS | Ciba SC Holding AG (CH) | 2001-05-02 | — | — | EP | claimed |
| WO-2000003965-A1 | DERIVATIVES OF 1-OXYL-4-HYDROXY- OR 4-AMINO-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH)ACRYLATE MONOMERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-01-27 | — | — | WO | claimed |
| US-5928558-A | STORAGE STABILITY | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| JP-57123165-A | — | — | None | — | — | JP | disclosed |
| WO-2024135708-A1 | METHOD FOR PRODUCING COMPOUND, POLYMER, COMPOSITION, AND PATTERN FORMATION METHOD | 三菱瓦斯化学株式会社 | 2024-06-27 | — | — | WO | disclosed |
| US-20230348351-A1 | COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMATION METHOD, INSULATING FILM FORMATION METHOD, AND METHOD FOR PRODUCING COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-11-02 | — | — | US | disclosed |
| US-20230174688-A1 | COMPOUND, (CO)POLYMER, COMPOSITION, METHOD FOR FORMING RESIST PATTERN, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING (CO)POLYMER | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-06-08 | — | — | US | disclosed |
| CN-114245792-A | Compound, polymer, composition for film formation, method for pattern formation, method for forming insulating film, method for producing compound, and method for producing iodine-containing vinyl polymer and acetylated derivative thereof | 三菱瓦斯化学株式会社 | 2022-03-25 | — | — | CN | disclosed |
| US-9718957-B2 | Biodegradable organic radical-functionalized polycarbonates for medical applications | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-08-01 | — | — | US | disclosed |
| WO-2017007010-A1 | SILICON-CONTAINING RESIN COMPOSITION | 東京応化工業株式会社 | 2017-01-12 | — | — | WO | disclosed |
| US-6740528-B2 | MONITORING REACTIVE IONS IN SAMPLE; OBTAIN SAMPLE, INCUBATE WITH MODULATOR OF IONIC ACTIVITY, ANALYZE WITH ELECTRON SPIN RESONANCE, COUNT REACTIVE IONS | HAKUTO CO., LTD. (JP) | 2004-05-25 | — | — | US | disclosed |
| US-20020048820-A1 | Method for measuring concentration of stable free radical compound | HAKUTO CO., LTD. | 2002-04-25 | — | — | US | disclosed |
| EP-1095006-A1 | DERIVATIVES OF 1-OXYL-4-HYDROXY-OR 4-AMINO-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH) ACRYLATE MONOMERS | Ciba SC Holding AG (CH) | 2001-05-02 | — | — | EP | disclosed |
| EP-1000032-A1 | INHIBITION OF PULP AND PAPER YELLOWING USING NITROXIDES AND OTHER COADDITIVES | Ciba SC Holding AG (CH) | 2000-05-17 | — | — | EP | disclosed |
| WO-2000003965-A1 | DERIVATIVES OF 1-OXYL-4-HYDROXY- OR 4-AMINO-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH)ACRYLATE MONOMERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-01-27 | — | — | WO | disclosed |
| US-5928558-A | STORAGE STABILITY | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-07-27 | — | — | US | disclosed |
| WO-1999005108-A1 | INHIBITION OF PULP AND PAPER YELLOWING USING NITROXIDES AND OTHER COADDITIVES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1999-02-04 | — | — | WO | disclosed |
| JP-S57123165-A | SYNTHETIC METHOD OF 4-ISOCYANO-2,2,6,6- TETRAMETHYLPIPERIDIN-1-OXYL | MEIJI MILK PROD CO LTD | 1982-07-31 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348351-A1 | COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMATION METHOD, INSULATING FILM FORMATION METHOD, AND METHOD FOR PRODUCING COMPOUND | PHOSPHO1, RER1, RIF1 | ADH1B 3489/4885ADH1A 1044/4885GAA 4793/4885 |
| US-20230174688-A1 | COMPOUND, (CO)POLYMER, COMPOSITION, METHOD FOR FORMING RESIST PATTERN, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING (CO)POLYMER | MCCC2, MMAB, INTS9 | ADH1B 2161/4885ADH1A 372/4885GAA 4702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.